Mary Zoe Baker, MD
Professor
Director of Clinical Services |
|
 |
Mailing Address:
920 Stanton L. Young Blvd., WP 1345
Oklahoma City, OK 73104-5020 |
Telephone:
(405) 271-3613
Fax:
(405) 271-7522 |
| Email: mary-baker@ouhsc.edu |
|

Research Interests
- Diabetes
- Osteoporosis
- Pituitary disease
- Thyroid disease
Education
| 1982 |
MD - University of Oklahoma College of Medicine, Oklahoma City, OK |
| 1977 |
MS - Oklahoma State University, Stillwater, OK |
| 1973 |
BA - Oklahoma State University, Stillwater, OK |

Hasan, M.K., Tierney, W.M. and Baker, MZ Severe Cholestatic Jaundice in Hyperthyroidism after Treatment with 131-Iodine. Am J Med Sci 2004; 328(6):1-3.
Howell P, Kariampuzha S, Kipgen W, Baker, MZ, Williams GR, Title T, Scofield RH. Non-surgical therapy of primary hyperparathyroidism: experience at a low volume institution. J Okla State Med Assoc, 94:561-565, 2001.
Downs, R.W., Bone, H.G., Mellwain, H., Baker, MZ, Yates, A.J., Lombardi, A., Krupa, D., Harning, R. An Open-label Extension Study of Alendronate Treatment in Elderly Women with Osteoporosis. Calcif Tissue Int 1999; 64(6):463-9.
Baker, MZ, Scofield, RH. Educational needs of internal medicine residency graduates: general internists versus subspecialists. Med Education 32:527-532, 1998.
|